Evidence map›Paper›PMID 37849554›Full record

ArticleACS medicinal chemistry letters2023

Development of Novel

Jian Rong, Tomoteru Yamasaki, Yinlong Li, Katsushi Kumata, Chunyu Zhao, Achi Haider, Jiahui Chen, Zhiwei Xiao, Masayuki Fujinaga, Kuan Hu and 7 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS medicinal chemistry letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Development of NovelACS pharmacology & translational science · 2025
    Article
  2. Development of a NovelACS pharmacology & translational science · 2025
    Article
  3. Development of a NovelMolecular pharmaceutics · 2025
    Article
  4. Radiosynthesis and evaluation of anAmerican journal of nuclear medicine and molecular imaging · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Jian RongDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.ORCID https://orcid.org/0000-0002-3960-1669
Tomoteru YamasakiDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Sciences, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Yinlong LiDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.
Katsushi KumataDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Sciences, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Chunyu ZhaoDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.
Achi HaiderDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.ORCID https://orcid.org/0009-0005-3704-0908
Jiahui ChenDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.ORCID https://orcid.org/0000-0001-9186-1110
Zhiwei XiaoDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.
Masayuki FujinagaDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Sciences, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.ORCID https://orcid.org/0000-0002-0418-229X
Kuan HuDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Sciences, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.ORCID https://orcid.org/0000-0003-2448-2254
Wakana MoriDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Sciences, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Yiding ZhangDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Sciences, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Lin XieDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Sciences, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Xin ZhouDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.
Thomas L CollierDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.
Ming-Rong ZhangDepartment of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Sciences, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.ORCID https://orcid.org/0000-0002-3001-9605
Steven LiangDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia 30322, United States.ORCID https://orcid.org/0000-0003-1413-6315
Harvard University · USNational Institutes for Quantum Science and Technology · JPEmory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orexin 2 receptors (OX

Identifiers

PMID37849554
PMCPMC10577698
OpenAlexW4387041590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.